Non-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years.
AffiliationSchool of Nursing, Midwifery and Social Work, The University of Manchester, Manchester, UK. email@example.com
MetadataShow full item record
AbstractEvidence suggests that compared to younger women, older women are less likely to receive standard management for breast cancer. Whether this disparity persists once differences in tumour characteristics have been adjusted for has not been investigated in the UK. A retrospective cohort study involving case note review was undertaken, based on the North Western Cancer Registry database of women aged > or =65 years, resident in Greater Manchester with invasive breast cancer registered over a 1-year period (n=480). Adjusting for tumour characteristics associated with age by logistic regression analyses, older women were less likely to receive standard management than younger women for all indicators investigated. Compared to women aged 65-69 years, women aged > or =80 years with operable (stage 1-3a) breast cancer have increased odds of not receiving triple assessment (OR=5.5, 95% confidence interval (CI): 2.1-14.5), not receiving primary surgery (OR=43.0, 95% CI: 9.7-191.3), not undergoing axillary node surgery (OR=27.6, 95% CI: 5.6-135.9) and not undergoing tests for steroid receptors (OR=3.0, 95% CI: 1.7-5.5). Women aged 75-79 years have increased odds of not receiving radiotherapy following breast-conserving surgery compared to women aged 65-69 years (OR=11.0, 95% CI: 2.0-61.6). These results demonstrate that older women in the UK are less likely to receive standard management for breast cancer, compared to younger women and this disparity cannot be explained by differences in tumour characteristics.
CitationNon-standard management of breast cancer increases with age in the UK: a population based cohort of women > or =65 years. 2007, 96 (8):1197-203 Br. J. Cancer
JournalBritish Journal of Cancer
- Is lack of surgery for older breast cancer patients in the UK explained by patient choice or poor health? A prospective cohort study.
- Authors: Lavelle K, Sowerbutts AM, Bundred N, Pilling M, Degner L, Stockton C, Todd C
- Issue date: 2014 Feb 4
- Elevated breast cancer mortality in women younger than age 40 years compared with older women is attributed to poorer survival in early-stage disease.
- Authors: Gnerlich JL, Deshpande AD, Jeffe DB, Sweet A, White N, Margenthaler JA
- Issue date: 2009 Mar
- Mortality rates among early-stage hormone receptor-positive breast cancer patients: a population-based cohort study in Denmark.
- Authors: Christiansen P, Bjerre K, Ejlertsen B, Jensen MB, Rasmussen BB, Lænkholm AV, Kroman N, Ewertz M, Offersen B, Toftdahl DB, Møller S, Mouridsen HT, Danish Breast Cancer Cooperative Group.
- Issue date: 2011 Sep 21
- Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
- Authors: Parise CA, Bauer KR, Brown MM, Caggiano V
- Issue date: 2009 Nov-Dec
- Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium.
- Authors: Luyeye Mvila G, Batalansi D, Praet M, Marchal G, Laenen A, Christiaens MR, Brouckaert O, Ali-Risasi C, Neven P, Van Ongeval C
- Issue date: 2015 Oct